Mass General Hospital

Harvard Medical School

Tag Archives | perimenopause

Women Outperform Men on Tests of Cognitive Functioning — Until Menopause

Many women report cognitive difficulties — forgetfulness, distractibility, feeling foggy — as they enter into the menopause. Looking at sex-related differences in memory, Rentz and colleagues examined 212 men and women between the ages of 45 and 55 years.  Participants completed a battery of cognitive tests and underwent hormonal assessments. On all measures of cognitive […]

Continue Reading · 0

In Brief: Telephone-Based CBT for Menopause-Related Insomnia

Peri- and postmenopausal women frequently complain of insomnia or poor sleep quality. Sleep disturbance is often attributed to nocturnal hot flashes.  While nocturnal hot flushes may be the cause of sleep disruption in many peri- and postmenopausal women, many of these women have an underlying primary sleep disorder, like restless leg syndrome or sleep apnea. […]

Continue Reading · 0
Photo by Christoph Lehmann https://www.flickr.com/photos/grooovy_easy/5255389744/in/photolist-91pfh1-5oVsER-pFpnRy-ec2MCd-gF9N97-5b3Vne-4NFhyn-8iQxd7-dUwWK-99SzT7-oEz9b9-6Bd2RD-64wPBn-bRpiQ6-6pQf1X-6CCqez-a7FBLH-9hhcsM-hhqhvC-Hx3Lu-w8y2T4-qpERyX-5FKSzJ-8MiyXg-2hvEdW-RBDAe-qxxAD4-4PRiP1-nE2Gaf-iGVY57-4VahiX-9DGHg9-r2EXfL-3hshNC-gGgjkR-buckND-jBwuQM-tQZcDc-qUzYP5-82899z-tyamDh-Hx9Ur-ciRYs5-jjzkxT-fp455D-2JrfTi-hy318h-5mZDc7-q61Z2D-dywyCa

Nonhormonal Management of Menopausal Vasomotor Symptoms: 2015 NAMS Position Statement

Since the Women’s Health Initiative (WHI) reported that the risks of menopausal hormone replacement therapy (HRT) outweighed its benefits, there has been a significant reduction in the use of HRT.  However, recent studies have suggested that many peri- and postmenopausal women experience significant symptoms for many years and that these symptoms have a marked impact […]

Continue Reading · 0

In Brief: Menopausal Symptoms More Severe in Sedentary Women

According to a recent study article published online in Menopause, having a sedentary lifestyle significantly affects the severity of perimenopausal symptoms.  This study included more than 6000 women aged 40 to 59 years who received care at urban health clinics across 11 Latin American countries. Women who exercised fewer than three times per week reported more severe menopause symptoms than […]

Continue Reading · 0
Photo by Christoph Lehmann https://www.flickr.com/photos/grooovy_easy/5255389744/in/photolist-91pfh1-5oVsER-pFpnRy-ec2MCd-gF9N97-5b3Vne-4NFhyn-8iQxd7-dUwWK-99SzT7-oEz9b9-6Bd2RD-64wPBn-bRpiQ6-6pQf1X-6CCqez-a7FBLH-9hhcsM-hhqhvC-Hx3Lu-w8y2T4-qpERyX-5FKSzJ-8MiyXg-2hvEdW-RBDAe-qxxAD4-4PRiP1-nE2Gaf-iGVY57-4VahiX-9DGHg9-r2EXfL-3hshNC-gGgjkR-buckND-jBwuQM-tQZcDc-qUzYP5-82899z-tyamDh-Hx9Ur-ciRYs5-jjzkxT-fp455D-2JrfTi-hy318h-5mZDc7-q61Z2D-dywyCa

Anxiety Symptoms and Risk for Perimenopausal Depression

A growing body of research indicates that the menopausal transition is a period of increased vulnerability to depressive illness.  Some women have experienced episodes of major depressive disorder (MDD) earlier in life and experience recurrent illness during the menopausal transition.  Other women, however, experience first lifetime-onset of MDD during this transition.  The identification of  specific […]

Continue Reading · 0

In Brief: Venlafaxine as Effective as Low-Dose Estradiol for Menopausal Sleep Symptoms

Which treatment is best for managing menopausal sleep problems? We tend to think of estrogen replacement therapy as being the best option for all menopausal symptoms; however, there are other options for managing menopausal symptoms, including serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors, and gabapentin. A recent study compares low-dose estradiol and low-dose venlafaxine for the […]

Continue Reading · 0
Photo by Christoph Lehmann https://www.flickr.com/photos/grooovy_easy/5255389744/in/photolist-91pfh1-5oVsER-pFpnRy-ec2MCd-gF9N97-5b3Vne-4NFhyn-8iQxd7-dUwWK-99SzT7-oEz9b9-6Bd2RD-64wPBn-bRpiQ6-6pQf1X-6CCqez-a7FBLH-9hhcsM-hhqhvC-Hx3Lu-w8y2T4-qpERyX-5FKSzJ-8MiyXg-2hvEdW-RBDAe-qxxAD4-4PRiP1-nE2Gaf-iGVY57-4VahiX-9DGHg9-r2EXfL-3hshNC-gGgjkR-buckND-jBwuQM-tQZcDc-qUzYP5-82899z-tyamDh-Hx9Ur-ciRYs5-jjzkxT-fp455D-2JrfTi-hy318h-5mZDc7-q61Z2D-dywyCa

Research Study: Vortioxetine for Perimenopausal and Postmenopausal Women

The menopausal transition is a difficult time for many women.  There is an increased risk of depressive episodes during this transition in the reproductive lifecycle, and the majority of women will experience symptoms related to perimenopause (such as hot flashes, sleep disturbance, and cognitive complaints). Vortioxetine (brand name Brintellix) is a novel antidepressant that was […]

Continue Reading · 0

New Research from the CWMH: Armodafinil for Menopause-Related Fatigue

Several recent articles indicate that the burden of menopausal symptoms is greater than generally perceived.  About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the menopause phase.  For most, the symptoms are manageable, but for a sizeable subset of midlife women, these symptoms can negatively […]

Continue Reading · 0

Position Paper: Non-Hormonal Treatments for Vasomotor Symptoms

A recent paper from the European Menopause and Andropause Society (EMAS) reviews non-hormonal therapy options for the treatment of  menopausal vasomotor symptoms. This EMAS position paper provides guidance for treaters managing peri- and postmenopausal women who cannot or do not want to use hormones to manage their symptoms.  While the information here is not new, […]

Continue Reading · 0

Meta-Analysis:  Acupuncture Effective for Menopausal Vasomotor Symptoms

Over the last decade, various studies have evaluated the effectiveness of acupuncture for the treatment of menopausal vasomotor symptoms.  In a recent meta-analysis, studies that reported on the frequency or severity of hot flashes, menopause-related symptoms assessed using the Menopause Rating Scale (MRS), and quality of life (QoL) assessed using the Menopause-Specific Quality of Life (MSQoL) questionnaire were included.  Twelve studies with a total of 869 participants met the inclusion criteria and were included in the final analysis.

Continue Reading · 1